Mogidonto and Boutique Dental have been acquired by OdontoPrev
The owner of Mogidonto and Boutique Dental has sold the companies to OdontoPrev.
Founded in 1976 in Mogi das Cruzes, Brazil, Mogidonto is a vertical operator of private dental care plans, with more than 62,000 beneficiaries. It has its own service network, Boutique Dental, which has three units located in Mogi das Cruzes, Itaquaquecetuba and Suzano. Boutique Dental units perform more than 15,000 consultations per month and have 24-hour urgent and emergency care services. In addition to its own units, Mogidonto has a network of more than 650 accredited dentists in Brazil.
OdontoPrev, a publicly traded company since 2006, is the leader in dental plans in Latin America, with more than 7.5 million beneficiaries. The company has a network of dental surgeons with approximately 31,000 professionals in Brazil. The acquisition of Mogidonto and Boutique Dental consolidates OdontoPrev as the leader in the Alto Tietê region and reinforces its strategy to improve control over dental plan usage. OdontoPrev acquired Boutique Dental through its subsidiary, Clidec.
One of Oaklins’ teams in Brazil acted as lead advisor to the seller and the management of Mogidonto and Boutique Dental in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers, and assisted them until closing.
Talk to the deal team
Priscila Cardanha Rosas
Oaklins Fortezza Partners
Denis Salvador Morante
Oaklins Fortezza Partners
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more